TERBINAFINE-WT terbinafine (as hydrochloride) 250 mg tablet blister pack

Active ingredient:

terbinafine hydrochloride, Quantity: 281.28 mg

Available from:

Medis Pharma Pty Ltd

INN (International Name):

terbinafine hydrochloride

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate type A; magnesium stearate; hypromellose

Administration route:

Oral

Units in package:

42

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

? Treatment in adults of ringworm (tinea corporis, tinea cruris and tinea pedis) due to infection caused by dermatophytes such as Trichophyton (e.g. T. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum), Microsporum canis and Epidermophyton floccosum, where oral therapy is considered appropriate owing to the site, severity or extent of the infection, and the infection is not responsive to topical therapy. ? Onychomycosis in adults (fungal infection of the nail) caused by dermatophyte fungi.

Product summary:

Visual Identification: White to off-white, uncoated biconvex, bevelled edge tablet, engraved 'TER' and '250' with a break line on one side and plain on the other; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2014-03-20